Pasar al contenido principal

IMPACTO DEL METABOLISMO DE LOS ASTROCITOS SOBRE LA REGULACION EPIGENETICA DE LAS FUNCIONES NEURALES DURANTE EL DETERIORO COGNITIVO

PID2022-138813OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Endogenous mitochondrial hydrogen peroxide regulates neurogenesis during cortical development

  • Mengual, Regina
  • Bobo Jiménez, Verónica
  • Rodríguez, Cristina
  • Lapresa, Rebeca
  • García Rodríguez, Darío
  • Jiménez Blasco, Daniel
  • Cabiscol Català, Elisa
  • Ros Salvador, Joaquim
Reactive oxygen species (ROS), particularly superoxide anion (O) and hydrogen peroxide (HO), originating from mitochondria, are increasingly recognized as critical mediators of physiological signaling and cellular function. While in the adult brain, mitochondrial ROS, specifically mitochondrial HO, modulate metabolism and sustains cognitive processes, their role in the developing cerebral cortex remains undefined. Here, we leverage a knock-in mouse model constitutively expressing mitochondrially targeted catalase (mCAT) to attenuate mitochondrial HO levels and investigate their impact during cortical development. In neurosphere cultures derived from embryonic day 14.5 (E14.5) mCAT mice, reduced mitochondrial HO altered glutathione redox homeostasis and glucose metabolism leading to suppressed progenitor cell proliferation, without compromising viability. In vivo, neural progenitor cell (NPC) proliferation, neuronal differentiation and cortical layering were disrupted starting at gestational day E15. Together, these data uncover a physiological role for mitochondrial hydrogen peroxide in orchestrating neural precursor proliferation and differentiation, ultimately influencing mammalian cerebral cortex formation., This work was funded by Instituto de Salud Carlos III, co-funded by the European Union, (PI21/00727, PI24/00810, RD24/0009/0005 to AA; CB16/10/00282 to JPB), and funded by the European Union - NextGeneration EU, Recovery and Resilience Facility (RD21/0006/0005, PMP22/00084 to AA), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to AA and JPB), Agencia Estatal de Investigación (MICIU) (PID2022-138813OB-I00 and FEDER, UE to JPB; RED2022-134407-T to AA), and la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to JPB), the European Union's Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY, to A.A. and J.P.B.), and the European Research Council (ERC) Advanced Grant NeuroSTARS (ref. 101199747, to J.P.B.)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brightness and shadows of mitochondrial ROS in the brain

  • Jimenez-Blasco, Daniel
  • Almeida, Angeles
  • Bolaños, Juan P.
Mitochondrial reactive oxygen species (mROS) have been generally considered harmful byproducts wanted to clear when elevated to avoid brain damage. However, the abundance of mROS in astrocytes is very high -about one order of magnitude above that in neurons-, despite they are essential to preserve cell metabolism and animal behavior. Here, we have focused on this apparent ambiguity by discussing (i) the intrinsic mechanisms accounting for the higher production of mROS by the mitochondrial respiratory chain in astrocytes than in neurons, (ii) the specific molecular targets of astrocytic beneficial mROS, and (iii) how decreased astrocytic mROS causes excess neuronal mROS leading to cellular and organismal damage. We hope that this mini-review serves to clarifying the apparent controversy on the beneficial versus deleterious faces of ROS in the brain from molecular to higher-order organismal levels., Authors were supported by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PID2022-138813OB-I00; PDC2021–121013-I00; RED2018–102576-T to JPB; RED2022–134407-T to AA); Plan Nacional de Drogas (2020I028 to JPB); Instituto de Salud Carlos III (CB16/10/00282 to JPB; PI21/00727; PMP22/00084 and RD21/0006/0005 co-funded by the European Union, to AA); Marie Sklodowska-Curie Action HORIZON-MSCA-2021-DN-01 (101072759 to JPB and AAP), and Junta de Castilla y León (CS/151P20 co-funded by P.O. FEDER to AA; Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 to JPB, and Escalera de Excelencia CLU-2017-03 to JPB and AA). DJB is a recipient of a Juan de la Cierva-Incorporación contract (IJC2020–044230-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies

  • Olmo, Esther del
  • Barboza, Bianca
  • Delgado-Esteban, María
  • Escala, Nerea
  • Jimenez-Blasco, Daniel
  • López-Pérez, José L.
  • Cillero de la Fuente, Laura
  • Quezada, Elías
  • Munín, Javier
  • Viña, Dolores
  • Bolaños, Juan P.
  • San Feliciano, Arturo
Monoaminooxidases (MAOs) are important targets for drugs used in the treatment of neurological and psychiatric disorders and particularly on Parkinson's Disease (PD). Compounds containing a trans-stilbenoid skeleton have demonstrated good selective and reversible MAO-B inhibition. Here, twenty-two (Z)-3-benzylidenephthalides (benzalphthalides, BPHs) displaying a trans-stilbenoid skeleton have been synthesised and evaluated as inhibitors of the MAO-A and MAO-B isoforms. Some BPHs have selectively inhibited MAO-B, with IC50 values ranging from sub-nM to μM. The most potent compound with IC50 = 0.6 nM was the 3',4'-dichloro-BPH 16, which showed highly selective and reversible MAO-B inhibitory activity. Furthermore, the most selective BPHs displayed a significant protection against the apoptosis, and mitochondrial toxic effects induced by 6-hydroxydopamine (6OHDA) on SH-SY5Y cells, used as a cellular model of PD. The results of virtual binding studies on the most potent compounds docked in MAO-B and MAO-A were in agreement with the potencies and selectivity indexes found experimentally. Additionally, related to toxicity risks, drug-likeness and ADME properties, the predictions found for the most relevant BPHs in this research were within those ranges established for drug candidates., This work was supported by grants from the Spanish government MINECO-Challenges projects AGL2016-79813-C2-1-R and AGL2016-79813-C2-2-R. Dolores Viña thanks the financial support from the Consellería de Cultura, Educación e Ordenación Universitaria (EM2014/016 and Centro singular de investigación de Galicia acreditación 2016‐2019, ED431G/05) and the European Regional Development Fund (ERDF). Juan P. Bolaños is funded by the European Regional Development Fund, Agencia Estatal de Investigación (PID2022-138813OB-I00), HORIZON-MSCA-2021-DN-01 (ETERNITY, 101072759 ), Fundación La Caixa ( HR23-00793 ), Instituto de Salud Carlos III ( CB16/10/00282 ), Junta de Castilla y León ( CS/151P20 and Escalera de Excelencia CLU-2017-03 ). José Luis López-Pérez thanks SENACYT of Panama for a SNI stimulus award., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice

  • Fernández-Moncada, Ignacio
  • Lavanco, Gianluca
  • Fundazuri, Unai B.
  • Bollmohr, Nasrin
  • Mountadem, Sarah
  • Dalla Tor, Tommaso
  • Hachaguer, Pauline
  • Julio-Kalajzic, Francisca
  • Gisquet, Doriane
  • Serrat, Roman
  • Bellocchio, Luigi
  • Cannich, Astrid
  • Fortunato-Marsol, Bérénice
  • Nasu, Yusuke
  • Campbell, Robert E.
  • Drago, Filippo
  • Cannizzaro, Carla
  • Ferreira, Guillaume
  • Bouzier-Sore, Anne-Karine
  • Pellerin, Luc
  • Bolaños, Juan P.
  • Bonvento, Gilles
  • Barros, L. Felipe
  • Oliet, Stephane H. R.
  • Panatier, Aude
  • Marsicano, Giovanni
Astrocytes control brain activity via both metabolic processes and gliotransmission, but the physiological links between these functions are scantly known. Here we show that endogenous activation of astrocyte type-1 cannabinoid (CB1) receptors determines a shift of glycolysis towards the lactate-dependent production of D-serine, thereby gating synaptic and cognitive functions in male mice. Mutant mice lacking the CB1 receptor gene in astrocytes (GFAP-CB1-KO) are impaired in novel object recognition (NOR) memory. This phenotype is rescued by the gliotransmitter D-serine, by its precursor L-serine, and also by lactate and 3,5-DHBA, an agonist of the lactate receptor HCAR1. Such lactate-dependent effect is abolished when the astrocyte-specific phosphorylated-pathway (PP), which diverts glycolysis towards L-serine synthesis, is blocked. Consistently, lactate and 3,5-DHBA promoted the co-agonist binding site occupancy of CA1 post-synaptic NMDA receptors in hippocampal slices in a PP-dependent manner. Thus, a tight cross-talk between astrocytic energy metabolism and gliotransmission determines synaptic and cognitive processes., The microscopy was done in the Bordeaux Imaging Center a service unit of the CNRS-INSERM and Bordeaux University, member of the national infrastructure France BioImaging supported by the French National Research Agency (ANR-10-INBS-04). We thank all past and present members of Marsicano’s lab for useful discussions and for their invaluable support. This study was funded by Inserm (to G.M., A.P. and S.H.R.O.); CNRS (to A.P. and S.H.R.O.); the European Research Council (Micabra, ERC-2017-AdG-786467, to G.M.); Fondation pour la Recherche Medicale (DRM20101220445, to G.M); EMBO Long-term Fellowship ALTF87-2018 (to I.F-M.); the Human Frontiers Science Program (to G.M.); Region Aquitaine (CanBrain, AAP2022A-2021-16763610 and −17219710 to A.-K.B.-S., L.P., A.P. and G.M.); French State/Agence Nationale de la Recherche (ERA-Net Neuron CanShank, ANR-21-NEU2-0001-04, to G.M), (CaMeLS, ANR-23-CE16-0022-01 to G.M., A.P. and G.B.), (Hippobese, ANR-23-CE14-0004-03, to G.F. and G.M.), (BrainFuel, ANR-21-CE44-0023-01 to A.-K.B.-S., L.P and AP.), (Excigly, ANR-20-CE16-0009-03 to S.H.R.O.), (Astrocom ANR-19-CE16-0015 to A.P.), (ANR-19-CE14-0039 to L.B.); the French government in the framework of the University of Bordeaux’s IdEx “Investments for the Future” program / GPR BRAIN_2030 / RRI IMPACT, the Japan Society for the Promotion of Science (21K14738, to Y.N. and 19H05633, to R.E.C.) and the Japan Science and Technology Agency (JPMJPR22E9, to Y.N.), Fondation Alzheimer (to G.B.), the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PID2022-138813OB-I00 and PDC2021-121013-I00 to J.P.B); European Commission action HORIZON-TMA-MSCA-DN (ETERNITY, 101072759, to J.P.B), La Caixa Research Health grant LCF/PR/HR23/52430016 (to J.P.B. and G.M.) and Fondecyt 1230145 & BMBF-ANID 180045 (to L.F.B.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TET3 regulates terminal cell differentiation at the metabolic level

  • Mulet, Isabel
  • Grueso-Cortina, Carmen
  • Cortes-Cano, Mireia
  • Gerovska, Daniela
  • Wu, Guangming
  • Iakab, Stefania Alexandra
  • Jiménez-Blasco, Daniel
  • Curtabbi, Andrea
  • Hernansanz-Agustin, Pablo
  • Ketchum, Harmony
  • Manjarres-Raza, Israel
  • Wunderlich, F Thomas
  • Bolaños, Juan P.
  • Dawlaty, Meelad M.
  • Hopf, Carsten
  • Enríquez, José Antonio
  • Arauzo-Bravo, Marcos J.
  • Tapia, Natalia
17 páginas, 7 figuras, TET-family members play a critical role in cell fate commitment. Indeed, TET3 is essential to postnatal development due to yet unknown reasons. To define TET3 function in cell differentiation, we have profiled the intestinal epithelium at single-cell level from wild-type and Tet3 knockout mice. We have found that Tet3 is mostly expressed in differentiated enterocytes. In the absence of TET3, enterocytes exhibit an aberrant differentiation trajectory and do not acquire a physiological cell identity due to an impairment in oxidative phosphorylation, specifically due to an ATP synthase assembly deficiency. Moreover, spatial metabolomics analysis has revealed that Tet3 knockout enterocytes exhibit an unphysiological metabolic profile when compared with their wild-type counterparts. In contrast, no metabolic differences have been observed between both genotypes in the stem cell compartment where Tet3 is mainly not expressed. Collectively, our findings suggest a mechanism by which TET3 regulates mitochondrial function and, thus, terminal cell differentiation at the metabolic level., N.T is funded by Agencia Estatal de Investigación(RYC-201416359; SAF2015-66549-R; PID2019-105920RB-100), Ayudas Fundación BBVA2016 andGeneralitat Valenciana (ACIF-2021-195). D.G. and M.J.AB. have received funding from the European Union’s Horizon 2020 Research and Innovation programme (grant agreement N° 899417), Ministerio de Ciencia e Innovación (PID2020-119715GB-I00/AEI/ 10.13039/501100011033) and Instituto de Salud Carlos III (Infrastructure of Precision Medicine associated with ScienceandTechnology(IMPaCT) of the Strategic Action in Health (iDATA-MP)). J.P.B. is funded by MICIU/ AEI (PID2022-138813OB-I00, PID2019-105699RB-I00 /10.13039/ 501100011033 and FEDER, UE), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016) and the European Union’sHorizonEurope research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptomic and metabolic signatures of neural cells cultured under a physiologic-like environment

  • Fernández, Emilio
  • Warde, Moussa
  • Manjarrés-Raza, Israel
  • Bobo-Jimenez, Veronica
  • Martinez-Luna, Maria
  • Vicente-Gutiérrez, Carlos
  • Garcia-Rodriguez, Dario
  • Jimenez-Blasco, Daniel
  • Almeida, Angeles
  • Bolaños, Juan P.
Cultured brain cells are used conventionally to investigate fundamental neurobiology and identify therapeutic targets against neural diseases. However, standard culture conditions do not simulate the natural cell microenvironment, thus hampering in vivo translational insight. Major weaknesses include atmospheric (21%) O2 tension and lack of intercellular communication, the two factors likely impacting metabolism and signaling. Here, we addressed this issue in mouse neurons and astrocytes in primary culture. We found that the signs of cellular and mitochondrial integrity were optimal when these cells were acclimated to grow in coculture, to emulate intercellular coupling, under physiologic (5%) O2 tension. Transcriptomic scrutiny, performed to elucidate the adaptive mechanism involved, revealed that the vast majority of differentially expressed transcripts were downregulated in both astrocytes and neurons. Gene ontology evaluation unveiled that the largest group of altered transcripts was glycolysis, which was experimentally validated by metabolic flux analyses. This protocol and database resource for neural cells grown under in vivo-like microenvironment may move forward the translation of basic into applied neurobiological research., The projects that gave rise to these results were funded by MICIU/AEI (PID2022–138813OB-I00, PID2019–105699RB-I00/10.13039/501100011033 and FEDER, UE to J. P. B.; SAF2017–90794-REDT to A. A.), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J. P. B.), Instituto de Salud Carlos III (CB16/10/00282 to J. P. B.; PI21/00727, RD16/0019/0018, PMP22/00084 to A. A.), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017–03 to J. P. B. and A. A.) and the European Union’s Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThE bRaiN In healtThY aging and age-related diseases, ETERNITY; to J. P. B. and A. A.). Estefanía Prieto-García was a recipient of a position by the Fondo Social Europeo, Youth Employment Initiative, Junta de Castilla y León., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Weak neuronal glycolysis sustains cognition and organismal fitness

  • Jimenez-Blasco, Daniel
  • Agulla, Jesús
  • Lapresa, Rebeca
  • García-Macia, Marina
  • Bobo-Jimenez, Veronica
  • Garcia-Rodriguez, Dario
  • Manjarres-Raza, Israel
  • Fernandez, Emilio
  • Jeanson, Yannick
  • Khoury, Spiro
  • Portais, Jean-Charles
  • Padro, Daniel
  • Ramos-Cabrer, Pedro
  • Carmeliet, Peter
  • Almeida, Angeles
  • Bolaños, Juan P.
The energy cost of neuronal activity is mainly sustained by glucose1,2. However, in an apparent paradox, neurons modestly metabolize glucose through glycolysis3-6, a circumstance that can be accounted for by the constant degradation of 6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase-3 (PFKFB3)3,7,8, a key glycolysis-promoting enzyme. To evaluate the in vivo physiological importance of this hypoglycolytic metabolism, here we genetically engineered mice with their neurons transformed into active glycolytic cells through Pfkfb3 expression. In vivo molecular, biochemical and metabolic flux analyses of these neurons revealed an accumulation of anomalous mitochondria, complex I disassembly, bioenergetic deficiency and mitochondrial redox stress. Notably, glycolysis-mediated nicotinamide adenine dinucleotide (NAD+) reduction impaired sirtuin-dependent autophagy. Furthermore, these mice displayed cognitive decline and a metabolic syndrome that was mimicked by confining Pfkfb3 expression to hypothalamic neurons. Neuron-specific genetic ablation of mitochondrial redox stress or brain NAD+ restoration corrected these behavioural alterations. Thus, the weak glycolytic nature of neurons is required to sustain higher-order organismal functions., E. Prieto-García was a recipient of a position by the Fondo Social Europeo, Youth Employment Initiative, Junta de Castilla y León. Staff members (A. Rocher, H. Kulyk, N. Lager-Lachaud, L. Gales, F. Bellvert) of MetaToul (Toulouse, France, https://metatoul.fr) are gratefully acknowledged for technical support and access to MS facilities. The projects that gave rise to these results were funded by MICIU/AEI (PID2022-138813OB-I00, PID2019-105699RB-I00/10.13039/501100011033 and FEDER, UE to J.P.B.; SAF2017-90794-REDT to A.A.), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J.P.B.), the Instituto de Salud Carlos III (CB16/10/00282 to J.P.B.; PI21/00727, RD16/0019/0018, PMP22/00084 to A.A.), the Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to J.P.B. and A.A.) and the European Union’s Horizon Europe research and innovation programme under MSCA Doctoral Networks 2021 (101072759, FuEl ThE bRaiN In healtThY aging and age-related diseases (ETERNITY), to J.P.B. and A.A.). MetaToul is part of the national infrastructure MetaboHUB and is funded by the French National Research Agency (ANR) with grant number MetaboHUB-ANR-11-INBS-0010., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis

  • Cicuéndez, Beatriz
  • Mora, Alfonso
  • López, Juan Antonio
  • Curtabbi, Andrea
  • Pérez-García, Javier
  • Porteiro, Begoña
  • Jimenez-Blasco, Daniel
  • Latorre-Muro, Pedro
  • Vo, Paula
  • Jerome, Madison
  • Gómez-Santos, Beatriz
  • Romero-Becerra, Rafael
  • Leiva, Magdalena
  • Rodríguez, Elena
  • León, Marta
  • Leiva-Vega, Luis
  • Gómez-Lado, Noemi
  • Torres, Jorge L.
  • Hernández-Cosido, Lourdes
  • Aguiar, Pablo
  • Marcos, Miguel
  • Jastroch, Martin
  • Daiber, Andreas
  • Aspichueta, Patricia
  • Bolaños, Juan P.
  • Spinelli, Jessica B.
  • Puigserver, Pere
  • Enriquez, José Antonio
  • Vázquez, Jesús
  • Folgueira, Cintia
  • Sabio, Guadalupe
Obesity poses a global health challenge, demanding a deeper understanding of adipose tissue (AT) and its mitochondria. This study describes the role of the mitochondrial protein Methylation-controlled J protein (MCJ/DnaJC15) in orchestrating brown adipose tissue (BAT) thermogenesis. Here we show how MCJ expression decreases during obesity, as evident in human and mouse adipose tissue samples. MCJKO mice, even without UCP1, a fundamental thermogenic protein, exhibit elevated BAT thermogenesis. Electron microscopy unveils changes in mitochondrial morphology resembling BAT activation. Proteomic analysis confirms these findings and suggests involvement of the eIF2α mediated stress response. The pivotal role of eIF2α is scrutinized by in vivo CRISPR deletion of eIF2α in MCJKO mice, abrogating thermogenesis. These findings uncover the importance of MCJ as a regulator of BAT thermogenesis, presenting it as a promising target for obesity therapy., We thank Electron Microscopy Facility (Centro Nacional de Biotecnología, CSIC) for preparing samples (Epon embedding), obtaining the ultrathin sections and TEM visualization. The project that gave rise to these results received the support of a fellowship from” la Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/DR21/11880010 to B.C. C.F was funded with Sara Borrell (CD19/ 00078), NNF23SA0083952-EASO/Novo Nordisk New Investigator Award in Basic Sciences 2023, EFSD/Lilly Young Investigator Award 2022, Society for Endocrinology/Early Career Grant 2022, FSEEN/ Jóvenes endocrinólogos 2022, EFSD/Novo Nordisk Rising Star 2024, IBSA Foundation Fellowship Endocrinology 2023. This work has been supported by the following projects: PMP21/00057 funded by the Instituto de Salud Carlos III (ISCIII) - European Union (FEDER/FSE) “Una manera de hacer Europa”/ “El FSE invierte en tu futuro”/ Next Generation EU and cofunded by the European Union / Plan de Recuperación, Transformación y Resiliencia (PRTR); PID2022-138525OB-I00 de la Agencia Estatal de Investigación 10.13039/501100011033, financiado por MICIU/AEI/10.13039/501100011033 fondos FEDER and EU, PDC2021-121147-I00 and PID2019-104399RB-I00 funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/Plan de Recuperación Transformación y Resiliencia -PRTR; Grant RED2022-134397-T funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union NextGenerationEU/PRTR”; Fundación Jesús Serra; EFSD/Lilly Dr Sabio; 2017 Leonardo Grant BBVA Foundation (Investigadores-BBVA-2017); Comunidad de Madrid IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-373; Fundación AECC PROYE19047SABI. PreMed-Exp: PMP21/00057, PMP21/00113 Infraestructura de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021, Instituto de Salud Carlos III (GS, JLT). The project leading to these results has received funding from the” la Caixa” Foundation under the project code “HR24-00581” (G.S). G.S is a Miembro Numerario of the RACVE. J.P-G was supported by the fellowship from” la Caixa” Foundation (ID 100010434), the fellowship code is LCF/BQ/DR24/12080018. A.C was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement n. 713,673 and by Becas de doctorado INPhINIT “la Caixa” 2018. PLM acknowledges NIH NIDDK grant K99DK133502. M.M is supported by Instituto de Salud Carlos III (ISCIII) and the European Union project PI20/00743. P.A is supported by MCIU/AEI/FEDER, UE (PID2021-124425OB-I00) and Basque Government, Department of Education (IT1476-22) and PMP21/00080 de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021, Instituto de Salud Carlos III. J.P.B is funded by MICIU/AEI (PID2022-138813OB-I00), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016), Instituto de Salud Carlos III (CB16/10/00282) and the European Union’s Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY), AEI grants PID2019-105699RB-I00, PID2022-138813OB-I00 and PDC2021-121013-I00; HORIZON-MSCA-2021-DN-01grant 101072759; and La Caixa Research Health grant HR23-00793. PP acknowledges NIH grant R01DK136640. JAE was supported by competitive grants: PID2021-127988OB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Human Frontier Science Program (grant RGP0016/2018), Leducq Transatlantic Networks (17CVD04) and CIBERFES [CB16/10/00282], Centro de Investigación Biomédica. Instituto de Salud Carlos III.The CNIO and CNIC are supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation) and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endogenous mitochondrial hydrogen peroxide regulates neurogenesis during cortical development

  • Mengual, Regina
  • Bobo-Jiménez, Verónica
  • Rodríguez González, Cristina
  • Lapresa, Rebeca
  • García-Rodríguez, Darío
  • Jiménez-Blasco, Daniel
  • Cabiscol, Elisa
  • Ros, Joaquim
  • Delgado-Esteban, María
  • Bolaños, Juan P.
  • Almeida, Ángeles
Reactive oxygen species (ROS), particularly superoxide anion (O2•-) and hydrogen peroxide (H2O2), originating from mitochondria, are increasingly recognized as critical mediators of physiological signaling and cellular function. While in the adult brain, mitochondrial ROS, specifically mitochondrial H2O2, modulate metabolism and sustains cognitive processes, their role in the developing cerebral cortex remains undefined. Here, we leverage a knock-in mouse model constitutively expressing mitochondrially targeted catalase (mCAT) to attenuate mitochondrial H2O2 levels and investigate their impact during cortical development. In neurosphere cultures derived from embryonic day 14.5 (E14.5) mCAT mice, reduced mitochondrial H2O2 altered glutathione redox homeostasis and glucose metabolism leading to suppressed progenitor cell proliferation, without compromising viability. In vivo, neural progenitor cell (NPC) proliferation, neuronal differentiation and cortical layering were disrupted starting at gestational day E15. Together, these data uncover a physiological role for mitochondrial hydrogen peroxide in orchestrating neural precursor proliferation and differentiation, ultimately influencing mammalian cerebral cortex formation., This work was funded by Instituto de Salud Carlos III, co-funded by the European Union, (PI21/00727, PI24/00810, RD24/0009/0005 to AA; CB16/10/00282 to JPB), and funded by the European Union - NextGeneration EU, Recovery and Resilience Facility (RD21/0006/0005, PMP22/00084 to AA), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to AA and JPB), Agencia Estatal de Investigación (MICIU) (PID2022-138813OB-I00 and FEDER, UE to JPB; RED2022-134407-T to AA), and la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to JPB), the European Union's Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY, to A.A. and J.P.B.), and the European Research Council (ERC) Advanced Grant NeuroSTARS (ref. 101199747, to J.P.B.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neuronal immunoproteasome and PFKFB3-forced glycolysis: key players in multiple sclerosis

  • Rodríguez-López, Claudia
  • Bolaños, Juan P.
  • Lucas, José Javier
In a recent study published in Cell, Woo et al. 1 investigated the role of the immunoproteasome and the metabolic regulator 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in neurons in the context of multiple sclerosis (MS)-related IFNγ signaling, finding new therapeutic targets for neurodegeneration in MS and possibly other related neuroinflammatory neurodegenerative disorders. The immunoproteasome is a variant of the constitutive proteasome, where the core catalytic subunits PSMB5 (β5), PSMB6 (β1), and PSMB7 (β2) are replaced by the inducible subunits PSMB8 (β5i), PSMB9 (β1i), and PSMB10 (β2i), which display slightly different hydrolytic profiles. The expression of the inducible subunits increases in most cell types in response to IFNγ, resulting in improved class I antigen processing. However, beyond this immune system function, the immunoproteasome has also been found to play specific regulatory roles, like redox signaling and oxidative stress, among others, in many cell types, including neurons, and the induction of the immunoproteasome in neurons has been implicated in different neurodegenerative diseases, as first reported for Huntington’s disease.2, This work was supported by Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/ 501100011033/FEDER, UE) grants PID2021-123141OB-I00 to J.J.L. and PID2022-138813OB-I00 to J.P.B., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potentiation of mitochondrial function by mitoDREADD-Gs reverses pharmacological and neurodegenerative cognitive impairment in mice

  • Pagano Zottola, Antonio C.
  • Martín-Jiménez, Rebeca
  • Lavanco, Gianluca
  • Hamel-Côté, Geneviève
  • Ramon-Duaso, Carla
  • Rodrigues, Rui S.
  • Mariani, Yamuna
  • Khan, Mehtab
  • Drago, Filippo
  • Jean, Stephanie
  • Río, Itziar Bonilla-Del
  • Jimenez-Blasco, Daniel
  • Egaña-Huguet, Jon
  • Eraso-Pichot, Abel
  • Beriain, Sandra
  • Cannich, Astrid
  • Vidal-Palencia, Laura
  • Infantino, Rosmara
  • Julio-Kalajzić, Francisca
  • Gisquet, Doriane
  • Goncalves, Ania
  • Al-Younis, Inas
  • Baussan, Yann
  • Duvezin-Caubet, Stephane
  • Devin, Anne
  • Soria-Gomez, Edgar
  • Puente, Nagore
  • Bolaños, Juan P.
  • Grandes, Pedro
  • Pouvreau, Sandrine
  • Busquets-Garcia, Arnau
  • Marsicano, Giovanni
  • Bellocchio, Luigi
  • Hebert-Chatelain, Etienne
Many brain disorders involve mitochondrial alterations, but owing to the lack of suitable tools, the causal role of mitochondrial dysfunction in pathophysiological processes is difficult to establish. Heterotrimeric guanine nucleotide-binding (G) proteins are key regulators of cell functions, and they can be found within mitochondria. Therefore, we reasoned that the activation of stimulatory mitochondrial G proteins (Gs) could rapidly promote the activity of the organelle and possibly compensate for bioenergetic dysfunction. Here, we show that a mitochondria-targeted recombinant designer receptor exclusively activated by designer drugs (mitoDREADD-Gs) can acutely trigger intramitochondrial signaling to increase mitochondrial membrane potential and oxygen consumption. In vivo activation of mitoDREADD-Gs abolished memory alterations in cannabinoid-treated mice and in two mouse models of Alzheimer's disease and frontotemporal dementia. Thus, mitoDREADD-Gs enables the establishment of causal relationships between mitochondria and biological or disease-related processes and represents an innovative potential therapeutic approach for disorders associated with mitochondrial impairment., This work was funded by the Natural Sciences and Engineering Research Council of Canada (grant number RGPIN-2015-05880 to E.H.-C.), Canadian Health Research Institute (grant number 156238 to E.H.-C. and L.B.), Canada Research Chair program (to E.H.-C.) and ResearchNB (to E.H.-C.). This work was also supported by Inserm (to G.M. and L.B.); EU–FP7 (PAINCAGE, HEALTH-603191, to G.M.); the European Research Council (Endofood, ERC–2010–StG–260515; CannaPreg, ERC-2014-PoC-640923; Micabra, ERC-2017-AdG-786467, to G.M.); Fondation pour la Recherche Medicale (DRM20101220445 to G.M.; ARF20140129235 to L.B.); the Human Frontiers Science Program (to G.M.); Region Aquitaine (to G.M.); French State/Agence Nationale de la Recherche (LABEX BRAIN ANR-10-LABX-43 and ANR-23-ce14-0004-03 to G.M., ANR-19-CE14-0039 to L.B., ERA-Net Neuron CanShank ANR-21-NEU2-0001-04 to G.M., CaMeLS ANR-23-CE16-0022-01 to G.M., Hippobese ANR-23-CE14-0004-03 to G.M.); Region Nouvelle Aquitaine (APP ESR NAq 2020 to G.M.); and the French government in the framework of the University of Bordeaux’s IdEx ‘Investments for the Future—France 2030’ program / GPR BRAIN_2030 (to G.M. and L.B.). E.S.-G. was funded by MICIU/AEI (PGC2018-093990-A-I00 and PID2021-125763NB-I00). J.P.B. was funded by MICIU/AEI (PID2022-138813OB-I00 /10.13039/501100011033 and FEDER, UE), the Instituto de Salud Carlos III (CB16/10/00282) and the European Union’s Horizon Europe research and innovation programme under MSCA Doctoral Networks 2021 (101072759, FuEl ThE bRaiN In healtThY aging and age-related diseases (ETERNITY). G.M., A.B.-G. and J.P.B. are recipients of a grant from la Caixa Foundation (agreement LCF/PR/HR23/52430016). A.B.-G., L.P-V. and C.R.D. received funding from the DIUE de la Generalitat de Catalunya (SGR 00022, 2023 FI-3 00034), from the H2020 Excellent Science—European Research Council (948217) and the Ministry of Economy and Competitiveness (RTI2018-093667-A-100; PID2021-122795OB-I00). S.P. was funded by the European Union’s Horizon 2020 research and innovation programme under Marie Skłodowska-Curie grant agreement No. 676,144 (Synaptic Dysfunction in Alzheimer's Disease, SyDAD). Grant PID2019-107548RB-I00 funded by MICIU/AEI/10.13039/501100011033 (to P.G.); The Basque Government (grant number IT1620-22 to P.G.); and grant RD21/0009/0006 funded by Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR), ISCIII-Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS)-Red de Investigación en Atención Primaria de Adicciones (RIAPAd) (to P.G.). G.H.-C. was supported by a fellowship from New Brunswick Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Reprogramación metabólica en astrocitos por adquisición de mitocondrias exógenas

  • Yunta Sánchez, Sara
Trabajo presentado para lograr el título de Doctor por la Universidad de Salamanca, Programa de Doctorado en Biología Funcional y Genómica.--2025-07-04.--Calificación: Sobresaliente Cum Laude, La coordinación del estado metabólico en células neurales se establece a través de dinámicas de comunicación intercelular, donde la señalización mitocondrial emerge como un eje regulatorio fundamental. Así, la transferencia intercelular de estos orgánulos ha demostrado ser un evento fisio(pato)lógico en células neurales, con una especial relevancia en el Sistema Nervioso. Pese a los creciente avances en la caracterización estructural y funcional de la transferencia mitocondrial, su impacto sobre el remodelado metabólico en células receptoras y su correlato fisiológico en el mantenimiento metabólico del cerebro permanecen en gran parte inexplorados. Para abordar esta brecha de conocimiento, implementamos un modelo experimental in vitro que combina técnicas de trazado mitocondrial fluorescente con análisis metabólicos de alta eficiencia. Este diseño permitió estudiar la capacidad de transferencia mitocondrial entre células neurales y evaluar las consecuencias metabólicas de la adquisición de mitocondrias exógenas en astrocitos. Mediante dos enfoques - la interacción directa con neuronas primarias en co-cultivo, o la administración de mitocondrias aisladas de origen neural-, caracterizamos los posibles mecanismos de reconfiguración metabólica asociados a la internalización mitocondrial y, por ende, la función fisiológica de la transferencia mitocondrial. Los resultados obtenidos demuestran que la adquisición de mitocondrias neuronales por astrocitos induce un remodelado de la red mitocondrial y su morfología en las células receptoras. A nivel funcional, este proceso desencadena una reprogramación metabólica astrocítica mediada por mecanismos de señalización. Esta reconfiguración se manifiesta principalmente en un aumento de la ß-oxidación de ácidos grasos, acompañado de una estimulación de la cetogénesis y una activación astrocitaria hacia un fenotipo reactivo. Estos cambios se traducen en un aumento de liberación de cuerpos cetónicos al medio extracelular, y previsiblemente otros factores, que pueden ser captados por las neuronas para mejorar su respiración mitocondrial. Creemos que estos hallazgos aportan una valiosa información sobre cómo la transferencia mitocondrial opera como un sistema de señalización intercelular, que orquesta la cooperación metabólica astrocito-neurona. La internalización de mitocondrias neuronales por astrocitos activa rutas catabólicas generadoras de sustratos energéticos (cuerpos cetónicos) que son transferidos de vuelta a las neuronas, estableciendo un circuito de retroalimentación positiva. Las implicaciones de este estudio trascienden al ámbito básico, revelando que la plasticidad fenotípica de los astrocitos, tanto en su estado funcional como metabólico, puede ser modulado por señales mitocondriales exógenas. Esto abre perspectivas hasta ahora inexploradas en neurobiología y enfoques terapéuticos relacionados., Este trabajo ha sido financiado por la Agencia Estatal de Investigación (PID2019- 105699RB-I00; PID2022-138813OB-I00). Sara Yunta Sánchez obtuvo un contrato predoctoral de personal investigador de la Junta de Castilla y León cofinanciado con el Fondo Social Europeo (EDU/875/2021)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neuronal glycolysis meets mitophagy to govern organismal wellbeing

  • Jimenez-Blasco, Daniel
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
  • Bolaños, Juan P.
Neurons are exceptionally energy-demanding cells but have limited energy storage, relying on a constant supply of fuel and oxygen. Although glucose is the brain's main energy source, neurons reduce glycolysis under normal conditions. This surprising strategy helps to protect mitochondria by preserving nicotinamide-adenine dinucleotide (NAD+), a vital cofactor consumed by glycolysis. NAD+ is needed for sirtuin-driven mitophagy, a process that removes damaged mitochondria. By saving NAD+, neurons can maintain healthy, energy-efficient mitochondria. These mitochondria then use alternative fuels such as lactate and ketone bodies from astrocytes. Here, we discuss the way in which this balance between reduced glycolysis and active mitophagy supports brain function and overall metabolic health, highlighting a sophisticated system that prioritizes mitochondrial quality for long-term cognitive performance and systemic homeostasis., J.P.B. is funded by MICIU/AEI (PID2022-138813OB-I00/10.13039/501100011033 and FEDER, UE), the Instituto de Salud Carlos III (CB16/10/00282), the European Union’s Horizon Europe research and innovation programme under MSCA Doctoral Networks 2021 (101072759, FuEl ThE bRaiN In healtThY aging and age-related diseases (ETERNITY) and la Caixa Foundation (agreement LCF/PR/HR23/52430016). A.A. is funded by the Instituto de Salud Carlos III (PI24/00810, PMP22/00084 and RD24/0009/0005 co-funded by the European Union) FEDER; Junta de Castilla y León (CSI011P23)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Perinatal liver sympathetic innervation governs body size

  • Bobo-Jiménez, Verónica
  • Gomila Huguet, Silvia
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Angibaud, Julie
  • Sánchez Morán, Irene
  • Delgado-Esteban, María
  • González-Rodríguez, Agueda
  • Fernández-Jaén, Alberto
  • Ramos-Cabrer, Pedro
  • Nägerl, U. Valentin
  • Bolaños, Juan P.
  • Almeida, Angeles
Perinatal failure in the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis causes impaired body growth and central and autonomous neurodevelopmental disorders. However, whether a primary neurodevelopmental disorder causes organ misinnervation as a contributing factor in growth retardation is elusive. To interrogate this, here we generated a late embryonic neural-specific cdc20 homolog 1 (Cdh1) knockout mouse model, which exhibited a primary delay in early postnatal brain development. These mice displayed an intact GH-releasing hormone (GHRH)-GH-hepatic GH receptor (GHR) pathway despite a body growth retardation that could be reversed by IGF-1 administration in the early postnatal life. Mechanistically, liver sympathetic misinnervation impaired signal transducers and activators of transcription 5 (STAT5) phosphorylation, required for liver IGF-1 biosynthesis and release. We also report decreased blood levels of IGF-1 in a patient harboring a pathogenic mutation in Cdh1 that causes neurodevelopmental and growth delay. Taken together, these findings demonstrate that a primary neurodevelopmental defect disrupts sympathetic hepatic innervation, leading to a GH-independent growth retardation, thus establishing a positive feedback loop that propagates the disease presentation., The projects that gave rise to these results were funded by Instituto de Salud Carlos III (PI21/00727, RD21/0006/0005, PMP22/00084, PI24/00810 to A.A.; CB16/10/00282 to J.P.B.), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to A.A. and J.P.B.), Agencia Estatal de Investigación (MICIU) (PID2022-138813OB-I00 and FEDER, UE to J.P.B.; RED2022-134407-T to A.A.), and la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J.P.B.). The STED microscopy was done in the Bordeaux Imaging Center a service unit of the CNRS-INSERM and University of Bordeaux, member of the national infrastructure France BioImaging supported by the French National Research Agency (ANR-10-INBS-04) with the help of Patrice Mascalchi., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Signaling roles for astrocytic lipid metabolism in brain function

  • Bolaños, Juan P.
  • Almeida, Angeles
Astrocytes, the most abundant glial cell type in the central nervous system, have traditionally been viewed from the perspective of metabolic support, particularly supplying neurons with lactate via glycolysis. This view has focused heavily on glucose metabolism as the primary mode of sustaining neuronal function. However, recent research challenges this paradigm by positioning astrocytes as dynamic metabolic hubs that actively engage in lipid metabolism, especially mitochondrial fatty acid β-oxidation. Far from serving solely as an energy source, fatty acid ß-oxidation in astrocytes orchestrates reactive oxygen species-mediated signaling pathways that modulate neuron-glia communication and cognitive outcomes. This review integrates recent advances on astrocytic fatty acid ß-oxidation and ketogenesis, alongside other metabolic pathways converging on reactive oxygen species dynamics, including cholesterol metabolism and peroxisomal β-oxidation. In reframing astrocytic metabolism from energy provision to signaling, we propose new directions for understanding central nervous system function and dysfunction., JPB is funded by MICIU/AEI (PID2022-138813OB-I00 /10.13039/501100011033 and FEDER, UE), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016), the European Union’s Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY, and the European Research Council (ERC) Advanced Grant NeuroSTARS (ref. 101199747). A.A. is funded by Instituto de Salud Carlos III (PI21/00727, RD21/0006/0005, PMP22/00084; Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03) and MICIU/AEI (RED2022-134407-T)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Endogenous mitochondrial hydrogen peroxide regulates neurogenesis during cortical development

  • Mengual, Regina
  • Bobo Jiménez, Verónica
  • Rodríguez, Cristina
  • Lapresa, Rebeca
  • García Rodríguez, Darío
  • Jiménez Blasco, Daniel
  • Cabiscol Català, Elisa
  • Ros Salvador, Joaquim
Reactive oxygen species (ROS), particularly superoxide anion (O) and hydrogen peroxide (HO), originating from mitochondria, are increasingly recognized as critical mediators of physiological signaling and cellular function. While in the adult brain, mitochondrial ROS, specifically mitochondrial HO, modulate metabolism and sustains cognitive processes, their role in the developing cerebral cortex remains undefined. Here, we leverage a knock-in mouse model constitutively expressing mitochondrially targeted catalase (mCAT) to attenuate mitochondrial HO levels and investigate their impact during cortical development. In neurosphere cultures derived from embryonic day 14.5 (E14.5) mCAT mice, reduced mitochondrial HO altered glutathione redox homeostasis and glucose metabolism leading to suppressed progenitor cell proliferation, without compromising viability. In vivo, neural progenitor cell (NPC) proliferation, neuronal differentiation and cortical layering were disrupted starting at gestational day E15. Together, these data uncover a physiological role for mitochondrial hydrogen peroxide in orchestrating neural precursor proliferation and differentiation, ultimately influencing mammalian cerebral cortex formation., This work was funded by Instituto de Salud Carlos III, co-funded by the European Union, (PI21/00727, PI24/00810, RD24/0009/0005 to AA; CB16/10/00282 to JPB), and funded by the European Union - NextGeneration EU, Recovery and Resilience Facility (RD21/0006/0005, PMP22/00084 to AA), Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to AA and JPB), Agencia Estatal de Investigación (MICIU) (PID2022-138813OB-I00 and FEDER, UE to JPB; RED2022-134407-T to AA), and la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to JPB), the European Union's Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY, to A.A. and J.P.B.), and the European Research Council (ERC) Advanced Grant NeuroSTARS (ref. 101199747, to J.P.B.)